ArticleVaccines2026

Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.

Léa-J Blanchette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.